Picture of NovoCure logo

NVCR — NovoCure News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Novocure Ltd reports results for the quarter ended in June - Earnings Summary

* Novocure Ltd  NVCR.OQ  reported a quarterly adjusted loss
of 54
cents​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of 50
cents per share.
    * Revenue fell 10.5% to $126.05 million from a year ago;
analysts
expected $124.26 million. 
    * Novocure Ltd's reported EPS for the quarter was a loss
of 54
cents​.
    * The mean earnings estimate of analysts had fallen by
about 40%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Novocure Ltd shares had fallen by 2.8% this quarter and
lost 45.0% so far this year.
    * The company reported a quarterly loss of $57.42 million.
    * Wall Street's median 12-month price target for Novocure
Ltd is
$73.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data July
27 at 03:46 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.50          -0.54          Missed
 Mar. 31 2023      -0.32          -0.50          Missed
 Dec. 31 2022      -0.30          -0.36          Missed
 Sep. 30 2022      -0.26          -0.25          Beat

Recent news on NovoCure

See all news